Publisher's Synopsis
This thesis aims to provide a framework for analyzing the moral responsibilities of the global players in what I call the Global Health Crisis (henceforth GHC), with special attention devoted to the moral responsibilities of pharmaceutical companies. I defend the following claim: while all global players share certain responsibilities in remediating the negative effects of the GHC, different degrees of responsibility apply to different players according to their relation to the GHC and to those affected by it; in this regard, pharmaceutical firms have certain responsibilities that apply specifically to them as private owners of relevant medical knowledge.
